NT219, a novel agent designed to overcome tumor resistance to drug therapy, will be evaluated in combination with the ...

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of ...

Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with Keytruda for first-line treatment.

DUBAI, United Arab Emirates;February 2025 - Throat cancer is one of the fastest-growing cancers, and it is often linked to ...

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of ...

International Childhood Cancer Day aims to spread awareness about childhood cancers. Childhood cancers (0-14 years of age) ...

Purple Biotech (PPBT) is advancing into a Phase 2 study with NT219 in patients with recurrent/metastatic squamous cell carcinoma of the head ...

Exelixis’ next-generation tyrosine kinase inhibitor zanzalintinib is being tested for colorectal cancer, renal cell carcinoma ...

Swiss downhill racer Niels Hintermann said Saturday that he has been declared free of lymph node cancer. The 29-year-old ...

Exposure to radiation from head or neck CT imaging increased risk for childhood brain tumors, according to results of a ...